Disclosure of In-principal Approval received from BSE Limited for issue of 58,00,000 Equity Shares of Re. 1/- each at a price Rs. 6/- to Promoters and Non Promoters on Preferential basis.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.9 pts more than Nifty Microcap 250 and 11.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Achyut Healthcare Ltd has received in-principle approval from BSE for issuing 58,00,000 equity shares of Re. 1 each at a price not less than Rs. 6 per share to promoters and non-promoters on a preferential basis. The total potential raise is approximately Rs. 3.48 crore. This is a preferential allotment under SEBI ICDR Regulations, not a public issue. The company must now complete allotment and file a listing application within 20 days of allotment.
This preferential issue will dilute existing shareholders, with promoter and non-promoter investors coming in at Rs. 6/share. The capital raise is relatively small (~$0.4 million), but the inclusion of non-promoters in a preferential allotment is worth monitoring for any new strategic shareholders entering the company.